New Oncomine products enable immune response analysis of the tumor microenvironment, interrogation of BRCA 1-2 genes, and liquid biopsy research using cell-free DNA from breast and colon cancer samples CARLSBAD, Calif.–Thermo Fisher Scientific today announced four new additions to its portfolio of multi-biomarker targeted assays for cancer research, including the Oncomine Immune Response Research Assay, […]
Firms will collaborate to support Archer® FusionPlex® NGS-assay customers CHARLOTTE, N.C. and MILFORD, Mass., Nov. 9, 2016 /PRNewswire/ — SeraCare Life Sciences, a global provider of tools supporting assay development and laboratory QC, and ArcherDX, a leading provider in next-generation sequencing-based assays, are announcing at the AMP Annual Meeting a partnership on the development and […]
Leading molecular pathologists will share performance data demonstrating new faster droplet detection, higher throughput and automated analysis capabilities BILLERICA, Mass. and CHARLOTTE, NC — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the launch of its RainDrop Plus™Digital PCR System featuring faster droplet detection, higher throughput, and […]
New method most accurate to date CASE WESTERN RESERVE UNIVERSITY A MULTI-INSTITUTION ACADEMIC-INDUSTRIAL PARTNERSHIP OF RESEARCHERS LED BY CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE HAS DEVELOPED A NEW METHOD TO BROADLY ASSESS CELL COMMUNICATION NETWORKS AND IDENTIFY DISEASE-SPECIFIC NETWORK ANOMALIES. THE COMPUTER-BASED METHOD, CALLED INFLO, WAS DEVELOPED IN COLLABORATION WITH RESEARCHERS AT PHILIPS AND […]
Respected diagnostics industry expert will help lead efforts to capitalize on market opportunity for Cologuard MADISON, Wis. — Exact Sciences Corp. (Nasdaq: EXAS) today announced the appointment of Jeff Elliott as chief financial officer. Mr. Elliott, a former senior research analyst at Robert W. Baird & Co., joined Exact Sciences as vice president, business development and […]
SAN DIEGO– Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the tumor-profiling paradigm from a series of single-gene tests to a multi-analyte approach, providing a more thorough picture of a tumor’s genomic landscape. TruSight Tumor 170 offers an integrated DNA and RNA enrichment-based workflow, […]
A streamlined solution for the preparation of high-quality RNA-sequencing libraries PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of KAPA® RNA HyperPrep product, a robust RNA library preparation solution for a range of sample types and input amounts. These kits provide a single-tube workflow and decrease processing time by 30 […]
Newest Addition in Clinical Cancer Research Portfolio Aims to Establish a Standardized Method for Tumor Profiling SAN DIEGO– Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the tumor-profiling paradigm from a series of single-gene tests to a multi-analyte approach, providing a […]
Shenzhen, China—BGI today launched its latest high-throughput sequencing platform, BGISEQ-50, at the 11th International Conference on Genomics (ICG-11). It is a miniaturized sequencer that after BGISEQ-500 to continue to reinforce the NGS (Next Generation Sequencing). Based on the technique from combinatorial Probe-Anchor Synthesis (cPAS) and DNA Nanoballs (DNB) sequencing, BGISEQ-50 is a sharp, dedicated and […]
NEW YORK, NY & CAMBRIDGE, MASS. — Flatiron Health and Foundation Medicine, Inc. (NASDAQ:FMI) today announced the launch of a clinico-genomic database designed to help researchers and biopharmaceutical partners accelerate the development of targeted therapeutics and immunotherapies to treat cancer. The clinico-genomic database, containing information on nearly 20,000 patients, is one of the largest and most comprehensive information efforts […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
